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Background
Cardiac sarcoidosis (CS) may be life threatening because
of end-stage cardiomyopathy and sudden cardiac death.
The frequent absence of specific symptoms and lack of a
diagnostic method pose challenges in CS diagnosis. Endo-
myocardial biopsy is invasive and has low diagnostic sensi-
tivity due to sampling errors. Thus, non-invasive cardiac
imaging has an important role in detecting cardiac invol-
vement of sarcoidosis. Recently, cardiac magnetic reso-
nance (CMR) and 18F-fluoro-2-deoxyglucose positron
emission tomography (18F-FDG-PET) have been reported
as a promising diagnostic modality in identifying cardiac
involvement of sarcoidosis. Late gadolinium enhancement
(LGE) of CMR typically reveals areas of irreversible
damage, such as fibrosis, whereas T2-weighted short tau
inversion recovery black-blood image (T2-STIR BB)
reveals edematous tissue; 18F-FDG-PET reveals myocar-
dial inflammation. Particularly, the latter two modalities
are possibly useful in assessing the necessity or dose
of steroid therapy. We compared T2-STIR and 18F-
FDG PET results in patients with suspected cardiac
involvement.
Methods
We used “Japanese Ministry of Health and Welfare
(JMHW) guidelines for the diagnosis of CS” for this study.
Patients who met more than 2 major criteria, or 1major
and 2 minor criteria are defined as “definite” CS patients.
Those who met at least 1 major or minor criteria, but not
definite CS, are defined as “suspected” CS patients. Twenty
consecutive definite or suspected CS patients underwent
CMR and 18F-FDG-PET. The T2-STIR BB, LGE, and
18F-FDG PET data was interpreted by experienced physi-
cians. All subjects underwent evaluation of LV function
and structure using echocardiography.
Results
Nine of the 20 patients were definite CS patients, whereas
the other eleven were suspected CS patients. The sensitiv-
ity and specificity for diagnosing definite CS were 88.9%
and 54.5%, respectively, for 18F-FDG-PET and 55.6% and
18.2%, respectively, for T2-STIR BB. All subjects had pat-
chy or non-vascular distributed LGE pattern. When the
18F-FDG-PET and T2-weighted MRI images were com-
pared, 18/20 patients tested positive by one (n = 9) or
both (n = 9) of the two modalities. Of the nine patients
testing positive by only one modality, five were positive by
only T2-STIR BB and four by only 18F-FDG-PET. Two
other patients tested negative by both image modalities
but had clear involvement of the lungs and thus were sus-
pected to have had CS in the past, although not currently
active.
Conclusions
18F-FDG PET provided high sensitivity for diagnosing CS
in patients with suspected cardiac involvement. The speci-
ficity and sensitivity of T2-STIR BB were lower than those
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